Pyrones as inhibitors of cyclooxygenase-2
    6.
    发明授权
    Pyrones as inhibitors of cyclooxygenase-2 失效
    Pyrones作为环加氧酶-2的抑制剂

    公开(公告)号:US06465509B2

    公开(公告)日:2002-10-15

    申请号:US09892941

    申请日:2001-06-27

    IPC分类号: A61K3135

    CPC分类号: C07D309/38

    摘要: The invention encompasses the novel compounds of Formula I, which are useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions comprising compounds of Formula I as well as methods of treating cyclooxygenase-2 mediated diseases comprising administering to a patient in need of such treatment a non-toxic therapeutically effective amount of a compound of Formula I.

    摘要翻译: 本发明包括式I化合物,其可用于治疗环氧合酶-2介导的疾病。本发明还包括含有式I化合物的某些药物组合物以及治疗环加氧酶-2介导的疾病的方法,包括给予 需要这种治疗的患者是无毒的治疗有效量的式I化合物。

    Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents
    8.
    发明授权
    Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents 失效
    二苯基-1,2,3-噻二唑作为抗炎剂

    公开(公告)号:US5677318A

    公开(公告)日:1997-10-14

    申请号:US678274

    申请日:1996-07-11

    申请人: Cheuk Kun Lau

    发明人: Cheuk Kun Lau

    IPC分类号: C07D285/06 A61K31/38

    CPC分类号: C07D285/06

    摘要: The invention encompasses the novel compound of Formula I as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of Formula I.

    摘要翻译: 本发明包括式I的新型化合物以及治疗COX-2介导的疾病的方法,包括向需要这种治疗无效治疗有效量的式I化合物的患者给药。图像I 本发明还包括用于治疗包含式I化合物的COX-2介导的疾病的某些药物组合物。

    COMPOUNDS AND METHOD FOR TREATMENT OF CANCER
    9.
    发明申请
    COMPOUNDS AND METHOD FOR TREATMENT OF CANCER 有权
    化合物和治疗癌症的方法

    公开(公告)号:US20110152281A1

    公开(公告)日:2011-06-23

    申请号:US12810722

    申请日:2008-12-24

    摘要: The invention relates to a compound of Formula (I) and/or a pharmaceutically-acceptable salt, hydrate, solvate, tautomer, optical isomer, E-isomer, Z-isomer, or combination thereof, wherein X is selected from S or O; R5 is selected from a substituted or unsubstituted aromatic group, a substituted or unsubstituted heteroaromatic group, or (Formula II) and the remaining substituents are described herein; and a composition comprising the thiosemicarbazone and/or the semicarbazone. The invention also relates to a method of administration of a thiocarbazone and/or a semicarbazone; and use thereof to treat a cancer.

    摘要翻译: 本发明涉及式(I)化合物和/或其药学上可接受的盐,水合物,溶剂化物,互变异构体,旋光异构体,E-异构体,Z-异构体或其组合,其中X选自S或O; R5选自取代或未取代的芳族基团,取代或未取代的杂芳族基团或(式II),其余取代基在本文中描述; 和包含缩氨基硫脲和/或缩氨基脲的组合物。 本发明还涉及施用硫卡巴腙和/或缩氨基脲的方法; 及其用途来治疗癌症。